AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Total Liabilities 2019–2025
AbCellera Biologics Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- AbCellera Biologics Inc. total liabilities for the quarter ending December 31, 2025 were 390.0M, a 28.11% increase year-over-year.
- AbCellera Biologics Inc. total liabilities for 2025 were 390.0M, a 28.11% increase from 2024.
- AbCellera Biologics Inc. total liabilities for 2024 were 304.5M, a 9.32% decrease from 2023.
- AbCellera Biologics Inc. total liabilities for 2023 were 335.8M, a 9.15% increase from 2022.
- AbCellera Biologics Inc. total liabilities for 2022 were 307.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| AbCellera Biologics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $390 |
| 2024 | $304 |
| 2023 | $336 |
| 2022 | $308 |
| 2021 | $293 |
| 2020 | $175 |
| AbCellera Biologics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $390 |
| 2024-12-31 | $304 |
| 2023-12-31 | $336 |
| 2022-12-31 | $308 |
| 2021-12-31 | $293 |
| 2020-12-31 | $175 |
AbCellera Biologics Inc. Total Liabilities — FAQ
AbCellera Biologics Inc. (ABCL) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's total liabilities history?
The chart and table above show AbCellera Biologics Inc.'s total liabilities by year and by quarter, including the growth rate.